Laparoscopic versus open liver resection for hepatocellular carcinoma: initial experience in Greece

被引:12
作者
Sotiropoulos, Georgios C. [1 ]
Machairas, Nikolaos [1 ]
Stamopoulos, Paraskevas [1 ]
Kostakis, Ioannis D. [1 ]
Dimitroulis, Dimitrios [1 ]
Mantas, Dimitrios [1 ]
Kouraklis, Gregory [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Gen Hosp Laiko, Sch Med, Dept Propedeut Surg 2, Athens, Greece
来源
ANNALS OF GASTROENTEROLOGY | 2016年 / 29卷 / 04期
关键词
Laparoscopic hepatectomy; liver resection; hepatocellular carcinoma; liver cirrhosis; hospital stay;
D O I
10.20524/aog.2016.0067
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Liver resection represents the treatment of choice for a small proportion of patients with hepatocellular carcinoma (HCC), amenable to surgery. The remarkable evolution in surgical techniques during the last decades introduced laparoscopic hepatectomy in the operative management of HCC, even in the presence of liver cirrhosis. No comparative study on laparoscopic or open liver resection for HCC has been conducted in Greece yet. Methods Patients undergoing liver resection for HCC by one senior hepatobiliary surgeon in our Institution during the period 11/2011-02/2016 were prospectively sampled and retrospectively analyzed for the purposes of this study. Statistical analysis encompassed Student's t-test, Fisher's exact test, the Kaplan-Meier method/log rank test and Cox proportional hazard regression analyses. Results Eleven patients underwent laparoscopic and 21 open liver resection, respectively. Statistical differences between the 2 groups were observed for tumor size (P=0.04), major resections (P=0.01), Pringle maneuver (P=0.008), intraoperative blood transfusion (P=0.03), and duration of operation (P=0.004). Resection margins, and tumor recurrence showed no statistical differences. Three-year postoperative survival after laparoscopic and open hepatectomy was 100%, and 67%, respectively (P=0.06). Regression analysis for patient survival revealed prognostic value for BCLC staging, gamma-glutamyl transferase levels, laparoscopic hepatectomy, UICC stage, Dindo-Clavien classification, and hospital stay. Laparoscopic hepatectomy remained as independent predictor of survival by multivariate analysis (P=0.0142). Conclusion Laparoscopic hepatectomy for HCC in chronic liver disease represents a safe and innovative treatment tool in the management of these patients under the presupposition of careful patient selection.
引用
收藏
页码:521 / 529
页数:9
相关论文
共 37 条
  • [1] [Anonymous], 2010, J CLIN ONCOL, DOI [DOI 10.1093/ANN0NC/MDQ166), DOI 10.1200/JCO.2010.28.7805]
  • [2] Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
    Bruix, Jordi
    Reig, Maria
    Sherman, Morris
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : 835 - 853
  • [3] The International Position on Laparoscopic Liver Surgery The Louisville Statement, 2008
    Buell, Joseph F.
    Cherqui, Daniel
    Geller, David A.
    O'Rourke, Nicholas
    Iannitti, David
    Dagher, Ibrahim
    Koffron, Alan J.
    Thomas, Mark
    Gayet, Brice
    Han, Ho Seong
    Wakabayashi, Go
    Belli, Giulio
    Kaneko, Hironori
    Ker, Chen-Guo
    Scatton, Olivier
    Laurent, Alexis
    Abdalla, Eddie K.
    Chaudhury, Prosanto
    Dutson, Erik
    Gamblin, Clark
    D'Angelica, Michael
    Nagorney, David
    Testa, Giuliano
    Labow, Daniel
    Manas, Derrik
    Poon, Ronnie T.
    Nelson, Heidi
    Martin, Robert
    Clary, Bryan
    Pinson, Wright C.
    Martinie, John
    Vauthey, Jean-Nicolas
    Goldstein, Robert
    Roayaie, Sasan
    Barlet, David
    Espat, Joseph
    Abecassis, Michael
    Rees, Myrddin
    Fong, Yuman
    McMasters, Kelly M.
    Broelsch, Christoph
    Busuttil, Ron
    Belghiti, Jacques
    Strasberg, Steven
    Chari, Ravi S.
    [J]. ANNALS OF SURGERY, 2009, 250 (05) : 825 - 830
  • [4] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [5] EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
  • [6] 2-E
  • [8] Gagner M, 1992, SURG ENDOSC OTHER IN, V6, P97
  • [9] HASHIZUME M, 1995, SURG ENDOSC-ULTRAS, V9, P1289
  • [10] Retreatment With Sofosbuvir and Simeprevir of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed a Daclatasvir-Containing Regimen
    Hezode, Christophe
    Chevaliez, Stephane
    Scoazec, Giovanna
    Soulier, Alexandre
    Varaut, Anne
    Bouvier-Alias, Magali
    Ruiz, Isaac
    Roudot-Thoraval, Francoise
    Mallat, Ariane
    Feray, Cyrille
    Pawlotsky, Jean-Michel
    [J]. HEPATOLOGY, 2016, 63 (06) : 1809 - 1816